BMI Revises Pharmaceutical Market Assessment

BMI View: Australia's challenging economic situation is affecting its pharmaceutical market. Embracement of expensive patented drugs by the three main stakeholders - payers, prescribers and patients - is being superseded by the pragmatic delivery of medical services. We expect to see the formalisation of the practice of health economics, swifter uptake of generic drugs and increased involvement of the private sector in pharmaceutical purchasing.

To read the full article, please choose one of the following options: